# Citius Pharmaceuticals, Inc. (CTXR) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2022 | -$33M |
| 2021 | -$24M |
| 2020 | -$18M |
| 2019 | -$16M |
| 2018 | -$14M |
| 2017 | -$10M |
| 2013 | -$28,118 |
| 2012 | -$19,618 |
| 2011 | -$25,637 |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$32M |
| 2025-12-31 | -$9M |
| 2014-06-30 | -$1,305 |
| 2014-03-31 | -$49,829 |
| 2013-12-31 | -$499,193 |
| 2013-06-30 | -$3,436 |
| 2013-03-31 | -$9,336 |
| 2012-12-31 | -$636 |
| 2012-06-30 | -$6,181 |
| 2012-03-31 | -$6,699 |
| 2011-12-31 | -$2,196 |
| 2011-06-30 | -$7,095 |
| 2011-03-31 | -$7,106 |
| 2010-12-31 | -$8,995 |

Source: [MarketCapTrends](https://marketcaptrends.com/company/CTXR/operating-income)